It’s an exciting time in the retina field. Researchers at ARVO 2013 reported on newly identified genetic factors in AMD and novel treatments for the disease, as well as FDA approval of a retinal prosthesis for RP and a new anti-VEGF agent for wet
This year’s research includes studies on possible new dry eye indicators and treatments, contact lens solution efficacy and the lifelong impact of keratoconus.
Intrepid Presents: Innovations and Implementations in Practice Location: Renaissance Newport Beach Program Co-chairs: Nathan Lighthizer, OD, FAAO and John D. Gelles, OD, FIAO, FCLSA Earn 14 LIVE COPE Credits (approval pending)
Establishing a Partnership in the Effective Management of Patients with Diabetic Retinal Disease Location: The Palm Chicago Speakers: Steven Ferrucci, OD, FAAO, and Dilsher Dhoot, MD 7:30–8:30pm CST